This viewpoint highlights the broader applications of mifepristone and potential risks to patient safety, suggesting implications for obstetric and gynecologic care.
This Viewpoint discusses the broader medical value of mifepristone beyond abortion and the threat to patient safety for a variety of obstetric and gynecologic procedures that may be introduced by banning the medication.
No takes yet. Share an insight, caveat, or question.
Jessica Chen (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: